Marko Jakopović

4.7k total citations
93 papers, 937 citations indexed

About

Marko Jakopović is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Marko Jakopović has authored 93 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pulmonary and Respiratory Medicine, 36 papers in Oncology and 17 papers in Epidemiology. Recurrent topics in Marko Jakopović's work include Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Research Studies (17 papers) and Lung Cancer Diagnosis and Treatment (16 papers). Marko Jakopović is often cited by papers focused on Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Research Studies (17 papers) and Lung Cancer Diagnosis and Treatment (16 papers). Marko Jakopović collaborates with scholars based in Croatia, Austria and Germany. Marko Jakopović's co-authors include Miroslav Samaržija, Anish Thomas, Giuseppe Giaccone, Yuanbin Chen, Neven Žarković, Davor Tomas, Marija Poljak‐Blaži, Mateja Janković Makek, Luka Brčić and Jelena Knežević and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Marko Jakopović

81 papers receiving 912 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marko Jakopović Croatia 16 402 262 234 183 133 93 937
Yasushi Horimasu Japan 21 1.0k 2.5× 283 1.1× 202 0.9× 180 1.0× 60 0.5× 123 1.4k
Shingo Tanaka Japan 19 207 0.5× 125 0.5× 177 0.8× 160 0.9× 80 0.6× 68 904
Lutz Welker Germany 12 562 1.4× 65 0.2× 125 0.5× 172 0.9× 72 0.5× 36 907
Guodong Liu China 18 166 0.4× 253 1.0× 470 2.0× 124 0.7× 334 2.5× 59 1.1k
Jana Skřičková Czechia 17 431 1.1× 373 1.4× 218 0.9× 80 0.4× 93 0.7× 80 869
Kathleen M. Capaccione United States 13 209 0.5× 236 0.9× 283 1.2× 33 0.2× 120 0.9× 45 733
M A Forbes United Kingdom 15 147 0.4× 238 0.9× 423 1.8× 119 0.7× 146 1.1× 29 1.1k
Kakuhiro Yamaguchi Japan 15 470 1.2× 222 0.8× 96 0.4× 84 0.5× 38 0.3× 93 751
Shiyu Xiao China 15 138 0.3× 192 0.7× 219 0.9× 87 0.5× 112 0.8× 33 846

Countries citing papers authored by Marko Jakopović

Since Specialization
Citations

This map shows the geographic impact of Marko Jakopović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Jakopović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Jakopović more than expected).

Fields of papers citing papers by Marko Jakopović

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marko Jakopović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Jakopović. The network helps show where Marko Jakopović may publish in the future.

Co-authorship network of co-authors of Marko Jakopović

This figure shows the co-authorship network connecting the top 25 collaborators of Marko Jakopović. A scholar is included among the top collaborators of Marko Jakopović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marko Jakopović. Marko Jakopović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Samaržija, Miroslav, Marko Jakopović, Anas Aboud, et al.. (2025). Design of the first national lung cancer screening program in the European Union: the Croatian Model. European Radiology.
2.
3.
Rumora, Lada, Andrea Vukić Dugac, Marko Jakopović, et al.. (2024). Serum progastrin-releasing peptide in pneumonia, chronic obstructive pulmonary disease and early-stage primary lung cancers. Biochemia Medica. 35(1). 10702–10702.
4.
Klasić, Marija, Marija Milavić, Snježana Židovec Lepej, et al.. (2023). Infection with human cytomegalovirus, Epstein-Barr virus, and high-risk types 16 and 18 of human papillomavirus in EGFR-mutated lung adenocarcinoma. Croatian Medical Journal. 64(2). 84–92. 6 indexed citations
5.
6.
Popović‐Grle, Sanja, et al.. (2023). Monocyte related haematological indices in acute exacerbations of COPD – a new biomarker?. Monaldi Archives for Chest Disease. 94(3). 2 indexed citations
7.
Schelch, Karin, Thomas Mohr, Thomas Klikovits, et al.. (2023). Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis. Thoracic Cancer. 14(22). 2177–2186. 1 indexed citations
8.
Knežević, Jelena, et al.. (2023). The role of immunotherapy in neoadjuvant treatment of non-small cell lung cancer—a narrative review. 3. 43–43. 1 indexed citations
9.
Cerić, Timur, Marko Jakopović, Santiago Ponce Aix, et al.. (2021). 1654P A phase Ib/II study of the dual MDMX/MDM2 inhibitor, ALRN-6924, for the prevention of chemotherapy-induced myelosuppression. Annals of Oncology. 32. S1166–S1166. 2 indexed citations
10.
Vrdoljak, Eduard, Marko Jakopović, Lajos Géczi, et al.. (2020). Real-World Safety and Efficacy of Nivolumab in Advanced Squamous and Nonsquamous Non-Small-Cell Lung Cancer: A Retrospective Cohort Study in Croatia, Hungary, and Malta. Journal of Oncology. 2020. 1–9. 2 indexed citations
11.
Sedlić, Filip, Ana Šepac, Sunčana Sikirić, et al.. (2020). Mitochondrial ROS Induce Partial Dedifferentiation of Human Mesothelioma via Upregulation of NANOG. Antioxidants. 9(7). 606–606. 9 indexed citations
12.
Zemanová, Milada, Marko Jakopović, Martina Vrankar, et al.. (2020). Treatment patterns and real-world evidence for stage III non-small cell lung cancer in Central and Eastern Europe. Radiology and Oncology. 54(4). 447–454. 2 indexed citations
13.
Jakopović, Marko, et al.. (2020). Neutrophil-to-lymphocyte ratio can predict outcome in extensive-stage small cell lung cancer. Radiology and Oncology. 54(4). 437–446. 15 indexed citations
14.
Jakopović, Marko, et al.. (2018). [CANCER PATIENTS FOLLOW-UP – CROATIAN SOCIETY FOR MEDICAL ONCOLOGY CLINICAL GUIDELINES Part V: melanoma, sarcomas, central nerve system tumors, lung cancer].. PubMed. 139(1-2). 17–23. 2 indexed citations
15.
Jakopović, Marko, et al.. (2017). Immunotherapy in the treatment of non-small cell lung cancer. Hrčak Portal of scientific journals of Croatia (University Computing Centre). 45. 60–64. 1 indexed citations
16.
Plavec, Davor, et al.. (2014). The Epworth sleepiness scale 23 years after: Is daytime sleepiness still a valid screening tool for sleep apnea. European Respiratory Journal. 44(Suppl 58). P2286–P2286. 6 indexed citations
17.
Dugac, Andrea Vukić, et al.. (2014). Endothelial dysfunction and systemic inflammation in different COPD phenotypes. European Respiratory Journal. 44(Suppl 58). 2951–2951. 1 indexed citations
18.
Jakopović, Marko, Anish Thomas, Sanjeeve Balasubramaniam, et al.. (2013). Targeting the Epigenome in Lung Cancer: Expanding Approaches to Epigenetic Therapy. Frontiers in Oncology. 3. 261–261. 57 indexed citations
19.
Samaržija, Miroslav, et al.. (2010). Long-term Follow-up of Patients on Sildenafil From the Croatian Pulmonary Hypertension Registry. CHEST Journal. 138(4). 373A–373A. 1 indexed citations
20.
Samaržija, Miroslav, et al.. (2007). Successful use of activated recombinant factor VII in life threatening bleeding after thoracic surgery. Swiss Medical Weekly. 137(2728). 407–410. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasushi Horimasu Breakdown of academic impact, for papers by Shingo Tanaka Breakdown of academic impact, for papers by Lutz Welker Breakdown of academic impact, for papers by Guodong Liu Breakdown of academic impact, for papers by Jana Skřičková Breakdown of academic impact, for papers by Kathleen M. Capaccione Breakdown of academic impact, for papers by M A Forbes Breakdown of academic impact, for papers by Kakuhiro Yamaguchi Breakdown of academic impact, for papers by Shiyu Xiao
Rankless by CCL
2026